| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.36 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |